Vitamin K1

DRUG9 trials

Conditions

Atrial FibrillationCalciphylaxisCarboxylation LevelCardiovascular DiseasesEnd Stage Renal Disease on DialysisEnd Stage Renal Failure on DialysisEnd-stage Kidney DiseaseGlioblastoma

Phase 1

Study to Evaluate the Effect of Multiple Doses of BIRT 2584 XX Tablets on the Pharmacokinetic Parameters of Warfarin, Omeprazole, Caffeine, and Dextromethorphan in Healthy Male Volunteers

CompletedNCT02256813

Boehringer IngelheimHealthy

Start: 2005-09-30Updated: 2014-10-06

Phase 2

Vitamin K to Attenuate Coronary Artery Calcification in Hemodialysis Patients

CompletedNCT01528800

Dr. Rachel HoldenEnd-stage Kidney Disease

Start: 2012-11-30End: 2019-12-31Updated: 2021-06-28

Vitamin K Supplementation in Patients on Hemodialysis

CompletedNCT02324686

University Health Network, TorontoAtrial Fibrillation, End Stage Renal Failure on Dialysis

Start: 2014-01-31End: 2017-12-18Updated: 2018-02-06

Comparative Study Evaluating the Effect of Vitamin K1 Versus Vitamin K2 on Vascular Calcification in Dialysis Patients

CompletedNCT04477811

Ain Shams UniversityEnd Stage Renal Disease on Dialysis

Start: 2020-07-25End: 2021-01-01Updated: 2021-07-21

A Study of BPM31510 With Vitamin K1 in Subjects With Newly Diagnosed Glioblastoma (GB)

Active, not recruitingNCT04752813

BPGbioGlioblastoma, Glioblastoma Multiforme

Start: 2022-08-22End: 2030-08-26Target: 50Updated: 2026-01-26

Phase 3

Vitamin K1 to Slow Progression of Vascular Calcification in HD Patients

TerminatedNCT01742273

RWTH Aachen UniversityCardiovascular Diseases

Start: 2013-10-31End: 2020-07-17Updated: 2020-10-08

Better Evidence and Translation for Calciphylaxis

RecruitingNCT05018221

University of SydneyCalciphylaxis

Start: 2021-08-26End: 2029-12-31Target: 350Updated: 2025-08-13

Phase 4

Efficacy and Safety of Intravenous Vitamin K1 in Management of Acute Variceal Bleeding

CompletedNCT06839352

Zagazig UniversityVariceal Bleeding

Start: 2022-10-03End: 2024-12-30Updated: 2025-02-21

Unknown Phase

Comparison of Efficacy of Different Dosages Vitamin K2

CompletedNCT01194778

Maastricht University Medical CenterCarboxylation Level, Vitamin K-dependent Proteins

Start: 2009-10-31End: 2010-08-31Updated: 2010-09-03

Neuro-Oncology2025-11-01

TMET-22. BPM31510 engagement of the Warburg effect in GBM to therapeutically modulate tumor metabolism through ROS mediated processes preclinically and clinically

Neuro-Oncology2025-11-01

Abstract CT242: A phase 2 study of BPM31510 (a lipid nanodispersion of oxidized CoQ10) with vitamin K in combination with standard of care (SOC) RT and TMZ in glioblastoma multiforme (GBM) patients without prior therapy

Cancer Research2025-04-25

CTNI-27. <i>TRIAL IN PROGRESS</i> A PHASE 2 STUDY OF BPM 31510 (AN OXIDIZED COQ10-LIPID CONJUGATE NANODISPERSION) WITH VITAMIN K AND STANDARD CHEMORADIATION IN NEWLY DIAGNOSED GLIOBLASTOMA

Neuro-Oncology2023-11-011 citations

Inhibit progression of coronary artery calcification with vitamin K in hemodialysis patients (the iPACK-HD study): a randomized, placebo-controlled multi-center, pilot trial

Nephrology Dialysis Transplantation2022-05-3113 citations